InterventionsReview
Dose-stratified lipid-lowering efficacy and safety of oral PCSK9 inhibitors: a systematic review and meta-analysis
Journal of Cardiovascular Medicine
- Oral PCSK9 inhibitors
- PCSK9
- Lipid and ceramide metabolism
- Heterozygous familial hypercholesterolemia
- Apolipoprotein B
- Humans
The paper
Marchetta M, Granata LG, Kovacevic M et al.
Journal of Cardiovascular Medicine · 1 Sep 2026